These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Febrile convulsions, Treatment and prognosis]. Knudsen FU Ugeskr Laeger; 2001 Feb; 163(8):1098-102. PubMed ID: 11242670 [TBL] [Abstract][Full Text] [Related]
24. Body temperature regulation and anesthesia. Lenhardt R Handb Clin Neurol; 2018; 157():635-644. PubMed ID: 30459029 [TBL] [Abstract][Full Text] [Related]
25. Factor VII deficiency associated with valproate treatment. Unalp A; Dirik E; Kurul S Pediatr Int; 2008 Jun; 50(3):403-5. PubMed ID: 18533961 [No Abstract] [Full Text] [Related]
26. Valproic acid. Schneider S West J Med; 1980 Jan; 132(1):64-5. PubMed ID: 6769253 [No Abstract] [Full Text] [Related]
27. Asymptomatic hyperammonemia in children treated with valproic acid. Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804 [No Abstract] [Full Text] [Related]
28. Reversible cognitive and neurological symptoms during valproic acid therapy. Hommet C; Mondon K; de Toffol B; Constans T J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449 [No Abstract] [Full Text] [Related]
29. [Use of sodium dipropylacetate in the prevention of recurrences of febrile convulsions]. Cavazzuti GB Riv Neurol; 1977; 47(2):156-8. PubMed ID: 325627 [No Abstract] [Full Text] [Related]
30. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke. Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540 [TBL] [Abstract][Full Text] [Related]
31. Hallucinations after withdrawal of valproic acid. de Laat SA; Hillegers MH; Jansen FE; Braun KP; de Graeff-Meeder ER Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876 [TBL] [Abstract][Full Text] [Related]
32. Onychomadesis: a rare side-effect of valproic acid medication? Poretti A; Lips U; Belvedere M; Schmitt B Pediatr Dermatol; 2009; 26(6):749-50. PubMed ID: 20199458 [TBL] [Abstract][Full Text] [Related]
33. Carnitine deficiency during valproic acid treatment. Van Wouwe JP Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002 [TBL] [Abstract][Full Text] [Related]
35. [Study of the immunosuppressive effect of some anticonvulsants in children]. Massimo L; Pasino M; Rosanda Vadalá C; Tonini GP; Perutelli P; Saccomani L Minerva Pediatr; 1977 Apr; 29(12):837-41. PubMed ID: 327255 [No Abstract] [Full Text] [Related]
36. [Valproic acid induced-idiosyncratic hepatotoxicity]. Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756 [No Abstract] [Full Text] [Related]
37. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment. Ertam I; Sezgin AO; Unal I Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064 [No Abstract] [Full Text] [Related]
38. Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report. Pokorná P; Hronová K; Šíma M; Slanař O; Klement P; van den Anker JN; Tibboel D Eur J Clin Pharmacol; 2017 May; 73(5):647-649. PubMed ID: 28168312 [No Abstract] [Full Text] [Related]
39. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. Sinclair DB; Berg M; Breault R J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953 [TBL] [Abstract][Full Text] [Related]
40. [Paroxysmal tonic upward gaze deviation triggered by valproic acid within the context of focal epilepsy]. Cantarin-Extremera V; Gutierrez-Solana LG; Duat-Rodriguez A; Lopez-Marin L; Ruiz-Falco ML; Leon-Gonzalez M; Perez-Villena A Rev Neurol; 2011 Sep; 53(5):318-9. PubMed ID: 21796611 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]